[Percutaneous Coronary Interventions in Patients With ST-Elevation Myocardial Infarction: 10-Years Follow-up]

I S Bessonov1, V A Kuznetsov1, A O Dyakova1

  • 1Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk.

Kardiologiia
|July 29, 2020
PubMed

Insights

Long-term follow-up of ST-segment elevation myocardial infarction (STEMI) patients after endovascular revascularization shows significant major adverse cardiovascular and cerebrovascular events. Age over 65 and incomplete revascularization independently predict death within 10 years.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • ST-segment elevation acute myocardial infarction (STEMI) requires timely intervention.
  • Endovascular revascularization is a primary treatment for STEMI.
  • Long-term outcomes and mortality predictors following STEMI treatment are crucial for patient management.

Purpose of the Study:

  • To evaluate the 10-year outcomes of patients with STEMI treated with endovascular revascularization.
  • To identify independent predictors of death in this patient cohort.

Main Methods:

  • Retrospective analysis of 283 STEMI patients undergoing percutaneous coronary interventions (PCI) from 2006-2009.
  • Assessment of 10-year incidence of all-cause and cardiovascular death, recurrent myocardial infarction (MI), repeated PCI, stroke, and stent-related complications.
  • Evaluation of Major Adverse Cardiovascular and Cerebrovascular Events (MACE) using Cox proportional hazards regression.

Main Results:

  • A total of 204 patients (72.1%) were followed for a mean of 120.1 months.
  • All-cause mortality was 25.5%, with cardiovascular death at 19.1%.
  • Recurrent MI occurred in 21.6%, and MACE in 60.3% of patients.
  • Age ≥65 years (OR 3.75) and incomplete coronary revascularization (OR 3.09) were independent predictors of death.

Conclusions:

  • STEMI patients treated with endovascular revascularization experience moderate mortality and high rates of MACE over 10 years.
  • Recurrent cardiovascular complications are primary drivers of mortality.
  • Advanced age and incomplete revascularization are key predictors of long-term mortality in STEMI patients.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
514
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
163
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
123
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
142
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
277
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
737